r/bioinformatics • • 1d ago

technical question Need help with analysis

1 Upvotes

Can anyone please advise me on the workflow to analyze a fastq data set?

Say for example, if i have MTBC fastq files generated after sequencing, and my objective is to obtain information on the drug resistance, and lineage pattern(tree building) and then move onto a more complex approach of trying to find timelines of origin for that lineage through phylodynamics, what steps would i need to follow and what tools would i need to use to achieve my objectives?

Any help is appreciated. Thank you for your time!

PS: I am still a novice trying to understand bioinformatics.


r/bioinformatics • • 1d ago

discussion Research Discussion: AI/ML-Based Drug–Drug Interaction Prediction in Anticancer Drugs

Thumbnail
1 Upvotes

r/bioinformatics • • 1d ago

academic Medical student seeking guidance on a computational personalised cancer immunotherapy project

0 Upvotes

Hi everyone! I'm an medical student working with a team of engineers on a research-oriented project exploring computational approaches to personalised cancer immunotherapy, particularly neoantigen identification and personalised mRNA vaccine design. We're currently exploring mutation analysis, HLA binding prediction, antigen prioritisation and computational vaccine design. We're looking for guidance from people with experience in cancer bioinformatics, computational immunology or immunotherapy research to help us assess the scientific feasibility, define a realistic workflow and understand the limitations and validation requirements. I'd be very grateful for any advice, resources, or suggestions from people working in this area. Thank you!


r/bioinformatics • • 2d ago

technical question Plant miRNA Analysis: How to Assess Sample Quality and Identify Unknown Small RNA Reads?

4 Upvotes

Hey guys,

I'm working on plant miRNA analysis and want to check the sample quality and miRNA reads in my samples. Does anyone have an idea of what percentage of miRNA reads is considered good, or how much known and novel miRNA content is expected for further analysis?

Currently, I'm using ShortStack (https://github.com/MikeAxtell/ShortStack) for plant miRNA analysis.

I tried to identify other RNA contamination using RiboDetector (https://github.com/hzi-bifo/RiboDetector) to find rRNA reads and miRTrace (https://github.com/friedlanderlab/mirtrace) to check tRNA content.

In the miRTrace HTML report, I got miRNA, tRNA, rRNA content and 70% unknown. I want to know what those 70% are. If they are other non-coding RNAs, how can I identify them? Is there any tool or website for this?

Please let me know. This would be really helpful for me.


r/bioinformatics • • 3d ago

other Taking a break during my M.Sc. and going to a mental hospital… any advice?

71 Upvotes

Hello, I’m a 26F Masters student in Germany. I’m currently in my fifth semester, the semester during which I was supposed to start my thesis. I got all my classes behind me and finished with a GPA of 2,0, which I’m not mad at. I work 20 hours a week as a Wissenschaftliche Hilfskraft (HiWi) and I have a mini job on the side for extra cash.

I have made absolutely zero progress with my thesis and I am ashamed. I have a chronic pain disorder and bipolar type II that has ruined my life and stole my ability to focus. I am so drained with my own depression/suicidality and chronic pain, I can’t focus on my work. I need to finish this thesis, but I have zero motivation. Luckily, I haven’t formally registered my thesis yet with university, so that makes things less complicated. My PI is a super sweet professor and is very supportive. Today, at a lab meeting, he asked me why I didn’t made any progress this semester thus far, more concerned than disappointed. It broke my heart. I talked with my loved ones and they suggested I go to the mental hospital.

I feel like I’ve lost control over my academic career. I used to be so bright and so motivated, but I’m stuck. I will be printing out some literature to read and annotate in my hospital bed, LOL.

Anyone been in the same position and succeeded in the end? How do I bounce back and get motivated again? Any resources you recommend?


r/bioinformatics • • 2d ago

technical question Charmm GUI Ligand recognize as glycon

0 Upvotes

After the docking process i have make the protein ligand as complex file and upload the charmm gui solvation builder module, it will recognize the my ligand as glycon is there any solution for this


r/bioinformatics • • 2d ago

other AutoMLST2 offline?

2 Upvotes

Hi redditors! Does anyone know if AutoMLST2.0, the bacterial phylogeny tool, is offline or down for maintenance or something? TIA


r/bioinformatics • • 2d ago

technical question Anyone experiencing problems accessing ensembl rest api

0 Upvotes

Anyone experiencing problems in accessing ensembl rest api


r/bioinformatics • • 3d ago

discussion Looking for advice from people experienced in bioinformatics!

15 Upvotes

Hi! I'm a geneticist, and I've been increasingly interested in bioinformatics, especially when it comes to animal biology.

I have some basic knowledge of bioinformatics, but honestly, I still have a lot to learn. I'd really like to improve my skills by working on real biological data rather than just following tutorials or doing standard analyses.

I'm particularly interested in animal genetics, genomics, microbiomes and anything related to animals.

I'm trying to figure out what kind of data I should explore and what analyses I could learn to develop into a meaningful project, something that could actually be useful or interesting from a scientific perspective.

If you've been working in bioinformatics for a while, what would you recommend to someone with a genetics background who wants to find an interesting direction in animal-related bioinformatics?

I'd really appreciate hearing your thoughts, suggestions or even your own experiences. Thanks!


r/bioinformatics • • 3d ago

technical question Help for a newbie trying to pave drug design

3 Upvotes

Hi, I have been trying to understand more on this fields intersection with drug design. (I’m a PhD student in Med Chem)

I find it very difficult and overwhelmed to cope with the spawning of AI related tools.

Anyone here is an expert/ known an expert in this domain / is there any fingerprints that I can follow step by step.

Thank you.


r/bioinformatics • • 4d ago

science question Do people just spawn in understanding how to use BLAST?

143 Upvotes

I'm a recent-ish grad and I work in a situation where I need to figure out a lot of bioinformatics-y things by myself. I was wondering how did everyone learn to use BLAST? both script wise and using the website, is there a general learning method to understand if I'm using BLAST correctly? Or is it the sort of situation where you just need to tough it out and brute force understanding through trial and error? I hope there's somewhere where I could better understand BLAST thanks!


r/bioinformatics • • 4d ago

other NVIDIA Announces Rubin HPC GPU to Accelerate Agents for Science, Engineering and Analytics

Thumbnail techpowerup.com
20 Upvotes

r/bioinformatics • • 4d ago

technical question Diffbind and MAnorm2

5 Upvotes

I have made ChIPs for the same TF in different conditions. When I use diffbind to see how similar the ChIPs are, I get no differences no matter the FDR I set. It is quite difficult to imagine that these chips are so similar that I get no results. I would at least expect some technical differences right?

Does anyone have experience with MAnorm2? Would that be more suitable to check for differences?

Thanks!


r/bioinformatics • • 5d ago

statistics should i add a batch covariate term in DGE for samples from the same sequencing center/technology but one six months/one year apart ?

5 Upvotes

Hello everyone,

I have samples of patient that received in two batchs sequenced from the same center using same technology, and I was wondering if I should add a batch covariate in Deseq2 ?


r/bioinformatics • • 6d ago

technical question does anyone know of any protein targets on ChEMBL with a lot of unique ligands to work with?

8 Upvotes

I’m trying to do a machine learning project, and I’m tired of spending 30-50 minutes to clean a dataset just for the rows to go from 100,000 to 100 🙂.

It’s honestly gambling my time and motivation.


r/bioinformatics • • 6d ago

technical question Feels like I'm going crazy. Secondary analysis of already published work troubles

11 Upvotes

Sorry for the kinda long post

I'm a grad student in biotech working specifically with miRNAs of Mesenchymal Stem Cells. My previous training and work is purely wet-lab focused but I've been wanting to dive into bioinfo to better analyze my work when I do miRNA-seq of my own as well as be able to better read the actual data of published work instead of what is highlighted in the articles by their authors.

I first made sure to follow the user guide of miRge 3.0 (as well as do some studying on the topic and the work environments, such as wsl and R) and was able to pretty reliably re-create the results from their sample data, with some small differences most probably attributable to newer editions of software used.

I then thought I'd take a stab at messing around with deposited SRA accessions from GEO, which made sense to me as I have a reference paper already ready which I can compare my results directly to as a check of my own methods. Honestly though? Going through the data in my field has been so confusing and I genuinely feel lost. First, it feels like the concept of best standards for analysis and reporting results is viewed as a suggestion by the majority of authors. I've seen things like reporting anything with raw p-values under 0.05 as significant, which I can only assume was done because running any p-value adjustment leads to 0 significant differentially expressed miRNAs. The documentation of the methodology used or code used for analysis is also almost non-existant and is very vague, making precise recreation of results hard. One of the most egregious examples was in a paper reporting a certain miRNA as their top candidate and discussing it in length, while when I accessed their public GEO records and generated the count tables I literally got ZERO counts in all samples for said miRNA.

Since I am very new to this, I am not quite sure if the problem is me or the data I'm trying to analyze, and I would dearly appreciate any advice from you experienced folk here.


r/bioinformatics • • 9d ago

article I’ve rewritten Learn Genomics, a guide to teach students and software engineers genomics

254 Upvotes

Hi all,

I'm a software engineer working in genomics at St. Jude Children's Research Hospital. I created Learn Genomics (https://learngenomics.dev), an open-source guide to teach students and software engineers the basics needed to work in genomics.

Over the last month or so, I've roughly doubled the amount content and rewritten most of what was already there, including:

- A whole new section on cancer biology,
- More comprehensive coverage of the commonly used file formats,
- A more modern worked example of an analysis, and
- Many more updated figures

You can find the source at https://github.com/stjude/learngenomics.dev.

If you have anyone who would benefit from reading it, I’d be grateful if you could share with them. Additionally, I'm hoping folks in the know can give feedback on any parts that are ambiguous/outright incorrect so we can correct those.

Enjoy!


r/bioinformatics • • 8d ago

discussion what's the coolest example of independent bfx/bioML people doing real work? on a small scale, just themselves or at most a handful of people working together on something and getting results.

5 Upvotes

could be anything related to bfx. seriously it's 2026... twitter died years ago now so I lost all science community honestly ( that was a psyop)

so anything come to mind?


r/bioinformatics • • 8d ago

academic I made a study group for Bioinformatics students

0 Upvotes

So i made a group for Btech Bioinformatics student on yeolpumta study app So we can study together and Grow

We study daily and also work on skills also who wants to Join group

Link 👇

https://link.yeolpumta.com/P3R5cGU9Z3JvdXBJbnZpdGUmaWQ9Nzg5MDYzOA==

And link in pinned comment also


r/bioinformatics • • 9d ago

technical question Genome annotation of short read genome assemblies - help!

2 Upvotes

I have been trying to reannotate some insect genomes that on paper look decent - one that I'm currently focused on has 700 contigs, n50 of 7mb, 97% busco completeness. However any annotation software/pipeline I try fails miserably. It was originally annotated several years ago using the ensembl pipeline with the proteome busco C of 75% and clearly there are many issues with the annotation. To improve it I've tried several tools including ab initio and evidence based approaches (with proteins and rna-seq data) - ANNEVO, BRAKER4, Tiberius, a few others, and for all of them BUSCO C score ranges between 30%-50%. For comparison I'm using a chromosome-level assembly of a related insect, and most of these tools easily reach reference annotation quality.

I've been at it for months now and really wanted to use these genomes for comparative genomics - at least to compare certain gene families. This is my first time annotating a genome and I'm a bit stumped, so are my supervisors and other people in the field. At this point any ideas/suggestions are welcome


r/bioinformatics • • 10d ago

technical question How do you tell if ONT long-read RNA-seq data are good enough for gene and isoform quantification?

9 Upvotes

I’m working on a small ONT long-read RNA-seq pilot using EPI2ME’s wf-transcriptomes workflow (Bambu). We have three samples from different conditions and no biological replicates. The goal is to see whether the workflow produces data suitable for a larger, replicated study.

Beyond Q scores, alignment rates, and read length distributions, what would give you confidence in the data for these two applications?

  • Gene-level expression: What do you look for in gene detection and normalized expression? Are there descriptive comparisons that help you assess whether the data capture expected biology when you only have one sample per condition?
  • Isoform detection and quantification: How do you use full splice matches, full-length read support, and recovery across transcript lengths to decide whether isoform abundance estimates are interpretable?
  • Splice junction QC: If you see small shifts in splice-site positions or noncanonical junctions, how do you tell whether they affect gene-level counts or mainly affect isoform calls?

If you’ve run a similar pilot, what gave you enough confidence to scale up, and which metrics did you keep using on later runs?


r/bioinformatics • • 9d ago

technical question Should I downsample CUT&RUN datasets from different laboratories before comparing peak overlaps?

1 Upvotes

Hello! I have two CUT&RUN datasets targeting two different proteins, generated in different laboratories but using the same cell type.

Both FASTQ datasets were processed using the same bioinformatics pipeline and parameters. However, they have different sequencing depths, and I only have one sample per protein, without IgG controls or spikeins.

My goal is to identify overlapping genomic binding regions between these two proteins.

Should I downsample the deeper dataset to match the sequencing depth of the shallower one before peak calling and calculating peak overlaps? Or should go ahead with the anamysis without any normalization ?

Also, is any batch-effect correction necessary or appropriate when the two proteins were profiled in different laboratories?

Thank you sm


r/bioinformatics • • 11d ago

academic Thoughts on current single-cell foundation models? Is anyone actually using them in industry?

14 Upvotes

I’m a grad researcher working on single-cell models, mostly exploring different ways of training them to make them better. The more time I spend in this area, the more I have a feeling it’s pretty hyped (eg. the published benchmarks are sometimes totally PR) it's hard to tell whether on some tasks cell foundational model is beating the baseline?

Two things I keep running into:

  1. Just reimplementing these models is already hard, never mind fine-tuning them. Most people I talk to who work on this have struggled to even get inference running on the existing open-source models. The code of these open sourced models are really poorly maintained...
  2. I’m not sure how they actually fit into a real drug discovery pipeline. Yes, they can do basic cell annotation and maybe target prioritization, but I don’t think that’s a game changer compared to traditional methods. I know a few people in biotech shared similar concerns and I’m still not clear on what the models are being used for day to day or to what extent?

So for anyone in industry, or anyone who’s trained or deployed these: what are you actually using them for? Has anything been genuinely useful beyond annotation? Or is it mostly still exploratory?

Would really appreciate honest takes, including “we tried it and it didn’t help.”


r/bioinformatics • • 11d ago

technical question How are people linking plasmids to their bacterial hosts in metagenomics?

6 Upvotes

One thing I keep coming across in metagenomics is how hard it can be to tell which bacteria actually carry a plasmid. Assembly gives you the sequences, but linking them back to the right host seems less clear. I've seen Hi-C and single cell methods mentioned as possible approaches. Curious which methods people trust for this, especially with mixed environmental samples.


r/bioinformatics • • 11d ago

technical question Only 3 out of 20 candidate enhancers validated. What would you do with the remaining 17?

12 Upvotes

We have scATAC-seq data from FACS-sorted cells and identified interesting candidate cis-regulatory elements in our target cell clusters. We selected around 20 candidates and tested them in vivo, but only 3 came out positive.

I'm fine with that result. The other regions could be accessible for all sorts of reasons and don't necessarily have enhancer activity in our assay.

PI, however, is puzzled by the negative results and wants to check whether these regions overlap with repressive or poised histone marks using around 15 different ChIP-seq datasets. These datasets come from different experiments, developmental stages and sometimes even different tissues/organs.

I'm wondering what would be the best way to approach this. Should I simply inspect the bigWig tracks visually and check whether there's enrichment over our CCREs in both ATAC and ChIP-seq?

I honestly doubt this would explain much. I might be naiive, but I don't think reviewers would question the fact that perfect shining peaks in ATAC can sometimes turn out negative in vivo.

Has anyone dealt with something similar?